Myriad Genetics Taps AI-Focused Tech Executive as New CTO
Event summary
- Raj Jampa appointed Chief Technology Officer of Myriad Genetics, effective June 1, 2026.
- Jampa previously held senior technology roles at Agilent Technologies, Exact Sciences, and Genomic Health.
- New CTO will focus on scaling AI capabilities and modernizing technology infrastructure.
- Appointment aims to strengthen digital foundation and enhance customer experience.
The big picture
Myriad Genetics' appointment of Raj Jampa as CTO underscores the growing importance of AI and digital transformation in precision medicine. The move comes as competitors like Exact Sciences and Agilent Technologies also invest heavily in scaling data-driven diagnostic capabilities. Jampa's background in modernizing enterprise platforms positions him to address both operational inefficiencies and competitive pressures in the molecular diagnostics space.
What we're watching
- AI Execution
- How quickly Jampa can operationalize AI-driven efficiencies across Myriad's enterprise.
- Technology Debt
- Whether Myriad can modernize its digital foundation without disrupting existing operations.
- Competitive Positioning
- The pace at which Myriad can differentiate itself through enhanced data and AI capabilities.
Related topics